Skip to main content

Research group Bergman/Agerberth - The AMP-group

We study the role of antimicrobial peptides (AMPs) in human immunity. The current focus is on respiratory tract infections, including tuberculosis, and the intestinal barrier function, especially in the context of HIV.

AMPs are expressed in mucosal tissues and by immune-cells. They constitute important effector molecules in the innate immune system. AMPs have potent antimicrobial activity against bacteria, viruses and fungi. In addition, AMPs function as "alarmins", i.e they activate and recruit cells from the adaptive immune system to the site of infection. AMP expression is tightly regulated but recent knowledge has revealed that substances such as vitamin D and phenylbutyrate (PBA) can induce AMP-expression in mucosal tissues and immune-cells.

Our aim is to translate basic findings on AMP-expression and regulation into clinical practice. In particular we work with a concept named “Host Directed Therapy”, which involves activation or induction of antimicrobial peptides by using small molecular compounds, such as vitamin D and Phenylbutyrate (PBA). Our aim is to identify novel and more potent inducers of AMP expression. In addition, we work with mechanistic studies on human tissues and cells but also perform clinical trials, where inducers of AMP-expression are investigated in humans.

Recently, we showed that vitamin D and PBA could activate autophagy in human macrophages, a process that is necessary to inhibit intracellular growth of Mycobacterium tuberculosis (Mtb). We could further show that autophagy and the control of Mtb-growth was depending on the human antimicrobial peptide LL-37.

We now plan to continue along these lines and to dissect the mechanisms in great detail. In addition, several clinical trials with vitamin D and/or PBA are ongoing or in the planning phase.

Research group leaders

Universitetslektor/klinisk anställning

Peter Bergman

Enhet: Avdelningen för klinisk mikrobiologi
E-post: Peter.Bergman@ki.se

Professor, senior

Birgitta Agerberth

Enhet: Avdelningen för klinisk mikrobiologi
E-post: Birgitta.Agerberth@ki.se

Our research in Media

The research on vitamin D/PBA and tuberculosis was recently presented on the KI website.

Previously, we have shown that patients with immunodeficiency can reduce their infectious burden and antibiotic consumption by vitamin D supplementation. Read article on the KI website here.

In another project, we have – together with a French group – shown that the antimicrobial peptide CRAMP can protect against type I diabetes in the mouse. Read lint the article published in Immunity.

Ongoing projects

These projects are carried out in close collaboration with several other research groups at KI.

  • Phenylbutyrate and Vitamin D as host directed therapy in tuberculosis – experimental and clinical studies in Bangladesh and Ethiopia
  • A cellular infection model to evaluate novel host directed therapy with implications for multi drug resistant bacteria
  • Studies of the expression and regulation of antimicrobial peptides – focus on transcription factors
  • The role of vitamin D in HIV – focus on the intestinal barrier function
  • Vitamin D and respiratory tract infections – experimental and clinical studies
  • Diagnostic and pathophysiological aspects of sepsis-causing bacteria

Group members

Professor, senior

Birgitta Agerberth

Enhet: Avdelningen för klinisk mikrobiologi
E-post: Birgitta.Agerberth@ki.se

Postdoc

Sultan Ahmed

Enhet: Avdelningen för klinisk mikrobiologi
E-post: sultan.ahmed@ki.se

Forskarstuderande

Salma Al Adwani

Telefon: 073-556 24 96
Enhet: Institutionen för laboratoriemedicin (LABMED), H5
E-post: salma.al.adwani@ki.se

Universitetslektor/klinisk anställning

Peter Bergman

Enhet: Avdelningen för klinisk mikrobiologi
E-post: Peter.Bergman@ki.se

Forskarstuderande

Harpa Karadottir

E-post: harpa.karadottir@ki.se

Anknuten

Catharina Missailidis

Enhet: Peter Bergmans grupp
E-post: catharina.missailidis@ki.se

Doktorand

Rokeya Sultana Rekha

Enhet: Avdelningen för klinisk mikrobiologi
E-post: rokeya.sultana.rekha@ki.se

Research techniques

  • Cell-culture
  • Immunohistochemistry
  • Expression analysis byq RT-PCR and Western blot
  • Microbiological work with bacteria
  • Biochemical purification of antimicrobial peptides using HPLC and mass-spectrometry
  • ChIP-assays
  • CRISPR/Cas9-gene editing

External funding

Swedish Research Council, Heart-Lung Foundation, Swedish Cancer Foundation, Stockholm County Council, Karolinska Institutet, Swedish Foundation for Strategic Research (SSF), the Groschinsky Foundation, the Scandinavian Society for Antimicrobial Research, Swedish Society for Physicians

Selected publications

28013511

28202713

27827460

27633343

26527065

26394045

26253786

26218841

26018761

25136085

23242238